Value Creation in a Company You Do Not Control

A minority growth investor creates value through four instruments: a board seat, information rights, protective provisions and operating engagement. None of them confers control, and each fails in a predictable way. The published evidence, most of it from venture capital, where the investor is ordinarily a minority holder, shows that monitoring and board participation change outcomes, while a veto pressed too hard can turn a minority holder into a fiduciary.

01The Minority Position

Growth equity is minority capital. The investor buys a meaningful but non-controlling stake in a company that already has revenue, a product and a management team, and it cannot replace the chief executive by majority vote. That is the position of growth equity between venture capital and buyout. Without the buyout toolkit, value creation depends on rights negotiated before the money moved and on the quality of the help given afterward.

The contracting evidence is clear that those rights can be separated and allocated individually. In a study of actual venture financings, Steven Kaplan and Per Strömberg found that the contracts separately allocate cash flow, voting, board, liquidation and other control rights, and that control is frequently contingent on performance: investors gain more control when the company performs poorly and the entrepreneur regains it as performance improves.

Investors negotiate accordingly: in a survey of 885 venture capitalists, Paul Gompers and coauthors found respondents particularly inflexible on control rights and liquidation rights, defining control rights to include board seats, vetoes on important decisions and protective provisions. A minority holder does not need control of the company; it needs the right slice of control over the right decisions at the right moments.

02The Minority-Position Levers

The table maps the four levers, with the observer right and key-person coverage shown as variants, to the National Venture Capital Association model documents (October 2025 editions) and to public evidence that each affects outcomes. The models are bracketed templates; every threshold is negotiated.

Two cautions apply. The best identified evidence concerns venture capital, whose investors are also minority holders; the growth-stage literature is thinner. Two sources are surveys of what investors say they do, which shows practice rather than effect. The airline-route study is the strongest causal result because it varies involvement after the investment is made.

03Board Representation

The board seat is often overrated and often underused. It is overrated because one director of five or seven cannot carry a vote alone, and because Delaware law makes the stockholders, all of them, the beneficiaries of the fiduciary duties owed by the corporation's directors and officers. The investor's designee is a fiduciary for the company, not an agent for the fund that nominated the seat. Its value lies less in votes than in timing and in people.

Timing matters most at moments of stress. Josh Lerner's study of venture-backed boards found that investor representation on the board increases around the time of chief executive turnover while the number of other outside directors stays constant, and that distance affects whether an investor joins a board at all. The seat earns its keep when leadership is in question.

People are the second channel. Natee Amornsiripanitch, Paul Gompers and Yuhai Xuan found that with venture capitalists on the board, companies are more likely to recruit managers and directors from the investors' networks and to exit through relationship-based acquisitions, with the effects strongest for well-connected investors. In life sciences, that means a regulatory head, a reimbursement lead or an independent director with clinical standing, sourced through the board.

Where a full seat is not available, the model Investors' Rights Agreement offers an observer who attends in a nonvoting observer capacity and receives the board materials, subject to exclusion for privilege, trade secrets and conflicts. A diligent observer supplies much of a director's value without the vote.

04Information Rights

Every other lever depends on information. A minority holder that does not see monthly cash, the budget and the capitalization table cannot know when to use its seat, its veto or its operating help. The model agreement gives Major Investors annual financial statements within 180 days of year-end, quarterly statements within 45 days, a quarterly capitalization statement, optional monthly statements and the board-approved budget, plus a right to inspect the books and discuss the business with officers.

The contractual package matters because the statutory alternative is narrow. Under Section 220 of the Delaware General Corporation Law, as amended by the same 2025 legislation that rewrote Section 144 (85 Del. Laws, c. 6), a stockholder may inspect the corporation's books and records only on a written demand under oath, made in good faith and for a proper purpose, describing with reasonable particularity records specifically related to that purpose.

Section 220 is a litigation tool, not a monitoring system. The model agreement asks each investor to waive its Section 220 rights until the company goes public, preserving only the contractual rights, so an investor that signs the waiver without a complete Section 3.1 has given up the statutory floor for little.

The evidence that information access produces value is indirect but strong. Shai Bernstein, Xavier Giroud and Richard Townsend showed that when new airline routes reduced travel time between investors and existing portfolio companies, innovation and the likelihood of a successful exit both increased, and almost 90% of surveyed investors said direct flights increased their interaction with management and helped them understand the company's activities. In healthcare, the package should reach beyond the financial statements to the operating facts that move value: enrollment against plan in a clinical program, quality system findings, payer coverage decisions and the regulatory calendar. Templates rarely include them.

05Protective Provisions and Their Limit

In the model charter, the company may not, without the consent of the Requisite Holders, liquidate or effect a Deemed Liquidation Event, adversely amend the charter or bylaws, create senior or parity stock, change the authorized shares, pay dividends or redeem stock, issue equity in subsidiaries, or change the size of the board. An optional second list, requiring approval of the board including the Preferred Directors, reaches debt above a threshold, equity plans, the chief executive's hiring and pay, and the annual budget. The statutory class vote in Section 242(b)(2) attaches by its terms to a charter amendment that adversely affects a class; the model reaches the same acts whether taken "directly or indirectly by amendment, merger, consolidation" or otherwise.

The limit on this lever was set out in Basho Technologies Holdco B, LLC v. Georgetown Basho Investors, LLC, decided by the Delaware Court of Chancery on July 6, 2018. The court described how a minority investor, through preferred financings it led or co-led, gained blocking rights that enabled it to control the company's access to capital, and then used them, when the company was near the end of its cash, to force through a financing that was highly favorable to the investor and unfair to the company.

The court held the investor and its principal jointly and severally liable for $17,490,650 plus interest. The opinion states the general rule carefully: a blocking right standing alone is highly unlikely to support a finding of control, but a defendant that exercises actual control over a particular transaction can assume fiduciary duties for that transaction.

Delaware's 2025 amendments to Section 144 now define a controlling stockholder by statute: a majority holder, a holder with the right to elect a board majority, or a holder with power functionally equivalent to majority control by virtue of ownership or control of at least one-third of the voting power and power to exercise managerial authority over the business and affairs of the corporation. On February 27, 2026, the Delaware Supreme Court rejected the constitutional challenges to the amended Section 144 in Rutledge v. Clearway Energy Group LLC. For a minority growth investor, the veto is a shield against dilution and a cheap sale, never a lever to extract terms it could not win at the table.

06Operating-Partner Engagement

The fourth lever has no statutory home, and its value depends on whether management wants it. Surveying private equity investors, Paul Gompers, Steven Kaplan and Vladimir Mukharlyamov found that operating partners, professionals with primarily operating rather than financial experience, helped identify sources of value in 45% of deals before investment and 51% after. In venture, Gompers and his coauthors reported that investors describe providing strategic guidance (87%), connections to investors (72%) and customers (69%), operational guidance (65%), help hiring board members (58%) and help hiring employees (46%), and that healthcare investors spend somewhat more time helping their companies than information technology investors even though they serve on slightly fewer boards.

The strongest public evidence that this help changes companies comes from Thomas Hellmann and Manju Puri, who used hand-collected data on Silicon Valley start-ups to show that venture capital is related to professionalization measures such as human resource policies, the adoption of stock option plans and the hiring of a marketing vice president, and that venture-backed companies are more likely, and faster, to replace the founder with an outside chief executive. That professionalization, the policies, incentive plans and first senior commercial hires that a founder-run company lacks, is exactly the work a minority investor can do without control.

Two disciplines govern this lever. The first is cost transparency: in 2014 the director of the Securities and Exchange Commission's examination office described operating partners who are paid directly by portfolio companies or the funds without sufficient disclosure to investors, which he characterized as a "back door" fee. The second is legal form. A fund relying on the venture capital operating company exception to ERISA plan-asset treatment needs contractual rights directly between the investor and an operating company to substantially participate in, or substantially influence the conduct of, the management of the operating company. That definition doubles as a test: if the investor cannot name the decisions it influences, the right is decorative.

LeverVenture's position follows from the evidence. In a company the investor does not control, value comes from drafting the four levers precisely before closing, using the information rights to know when each matters, and spending most of the effort on operating help that management chooses to accept. That holds across all five sectors of the mandate, and most where AI is changing how a company operates. The veto stays in reserve; the board seat is used for people and for transitions.

07Frequently asked questions

How does a minority investor create value without control?

Through four negotiated levers: a board seat or observer right, contractual information and inspection rights, protective provisions that veto defined structural decisions, and operating engagement that management chooses to accept. Published research on venture-backed companies links board participation and monitoring to executive recruiting, innovation and successful exits.

Can protective provisions make a minority investor a controlling stockholder?

A blocking right standing alone is highly unlikely to establish control under Delaware law. In Basho Technologies (Del. Ch. 2018), however, a minority investor that used blocking rights over the company's access to capital to force through an unfair financing was treated as exercising actual control and held liable for breach of fiduciary duty.

What information rights are standard for a growth-stage minority investor?

The NVCA model Investors' Rights Agreement provides Major Investors with annual financial statements within 180 days, quarterly statements and a capitalization statement within 45 days, optional monthly statements within 30 days, the board-approved annual budget, and an inspection right. These covenants end at an initial public offering.

Nothing in this piece is investment, legal, tax or accounting advice, and nothing in it is an offer to sell or a solicitation of an offer to buy any security.